Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.78 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.73 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.73 |
| ▸ | CALCR | P30988 | 4/20 | 0.69 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.67 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.67 |
| ▸ | NMBR | P28336 | 1/20 | 0.65 |
| ▸ | GRPR | P30550 | 1/20 | 0.65 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.64 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.63 |
| ▸ | CCKBR | P32239 | 1/20 | 0.63 |
| ▸ | GLP1R | P43220 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29351932 | 0.91 | CRHR1 (0.74) | F2CRHR1CRHR2CALCRHCRTR1 | |
| SCHEMBL30432393 | 0.90 | F2 (0.72) | F2CRHR1CRHR2CALCRHCRTR1 | |
| SCHEMBL30498570 | 0.89 | CALCR (0.80) | F2CRHR1CRHR2CALCRHCRTR1 | |
| SCHEMBL30495663 | 0.89 | F2 (0.71) | F2CRHR1CRHR2CALCRHCRTR1 | |
| SCHEMBL30712965 | 0.89 | CALCR (0.71) | F2CRHR1CRHR2CALCRHCRTR1 | |
| SCHEMBL31362091 | 0.88 | CRHR1 (0.69) | F2CRHR1CRHR2CALCRHCRTR1 | |
| SCHEMBL30576931 | 0.88 | F2 (0.73) | F2CRHR1CRHR2CALCRHCRTR1 | |
| SCHEMBL31182519 | 0.88 | CALCR (0.68) | F2CALCRC5AR1 | |
| SCHEMBL29377468 | 0.88 | CALCR (0.73) | CRHR1CRHR2CALCRGLP1R | |
| SCHEMBL29939733 | 0.87 | CALCR (0.73) | F2CRHR1CRHR2CALCRHCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119432862-A | Preparation and application of dsRNA of plutella xylostella neuropeptide F genes NPF1 and NPF2 | 江苏省农业科学院 | 2025-02-14 | — | — | CN | claimed |
| WO-2024133655-A1 | PEST CONTROL COMPOSITION | Reckitt & Colman (Overseas) Hygiene Home Limited (GB) | 2024-06-27 | — | — | WO | claimed |
| US-11364285-B2 | Methods, compositions, and molecular targets that exploit synergies and symbioses in the termite gut | PURDUE RESEARCH FOUNDATION (US) | 2022-06-21 | — | — | US | claimed |
| EP-3621632-B1 | ANTIMICROBIAL PEPTIDES WITH ALPHA-CORE HELICES | LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT (US) | 2025-08-13 | — | — | EP | disclosed |
| CN-119432862-A | Preparation and application of dsRNA of plutella xylostella neuropeptide F genes NPF1 and NPF2 | 江苏省农业科学院 | 2025-02-14 | — | — | CN | disclosed |
| CN-119432862-A | Preparation and application of dsRNA of plutella xylostella neuropeptide F genes NPF1 and NPF2 | 江苏省农业科学院 | 2025-02-14 | — | — | CN | disclosed |
| CN-119432862-A | Preparation and application of dsRNA of plutella xylostella neuropeptide F genes NPF1 and NPF2 | 江苏省农业科学院 | 2025-02-14 | — | — | CN | disclosed |
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
| CN-118127021-B | DsRNA based on neuropeptide NPF gene, and preparation method and application thereof | 青岛农业大学 | 2024-07-26 | — | — | CN | disclosed |
| WO-2024133655-A1 | PEST CONTROL COMPOSITION | Reckitt & Colman (Overseas) Hygiene Home Limited (GB) | 2024-06-27 | — | — | WO | disclosed |
| CN-118127021-A | DsRNA based on neuropeptide NPF gene, and preparation method and application thereof | 青岛农业大学 | 2024-06-04 | — | — | CN | disclosed |
| US-20220380430-A1 | Non-Transgenic Functional Rescue of Neuropeptides | WORCESTER POLYTECHNIC INSTITUTE | 2022-12-01 | — | — | US | disclosed |
| WO-2022246187-A1 | NON-TRANSGENIC FUNCTIONAL RESCUE OF NEUROPEPTIDES | ORCESTER POLYTECHNIC INSTITUTE (US) | 2022-11-24 | — | — | WO | disclosed |
| US-20220281989-A1 | GPCR BINDING PROTEINS AND SYNTHESIS THEREOF | Twist Bioscience Corporation | 2022-09-08 | — | — | US | disclosed |
| US-11407837-B2 | GPCR binding proteins and synthesis thereof | Twist Bioscience Corporation (US) | 2022-08-09 | — | — | US | disclosed |
| US-11364285-B2 | Methods, compositions, and molecular targets that exploit synergies and symbioses in the termite gut | PURDUE RESEARCH FOUNDATION (US) | 2022-06-21 | — | — | US | disclosed |
| US-20220040253-A1 | Agonists of Human Kisspeptin Receptor for Modulating Sexual Desire | Université de Liège (BE) | 2022-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | F2 3164/4885CRHR1 195/4885CRHR2 386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.